{"id":578,"date":"2022-08-02T08:36:14","date_gmt":"2022-08-02T12:36:14","guid":{"rendered":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/?page_id=578"},"modified":"2022-08-22T16:25:01","modified_gmt":"2022-08-22T20:25:01","slug":"monkeypox-information-for-healthcare-professionals","status":"publish","type":"page","link":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/","title":{"rendered":"Monkeypox Information for Healthcare Professionals"},"content":{"rendered":"<div id=\"pl-578\"  class=\"panel-layout\" ><div id=\"pg-578-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-578-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-578-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<div id=\"content\" class=\"site-content\">\n<div id=\"primary\" class=\"content-area\">\n<p>If you are evaluating a patient suspected to have monkeypox, immediately report the suspected case to the <a href=\"https:\/\/www.vdh.virginia.gov\/local-health-districts\/\">local health department (LHD)<\/a>\u00a0using the\u00a0<a href=\"https:\/\/www.vdh.virginia.gov\/disease-prevention\/disease-reporting\/\">Confidential Morbidity Report Portal<\/a>\u00a0(Epi-1) or telephone, even if testing is being conducted at a commercial laboratory.<\/p>\n<\/div>\n<\/div>\n<footer id=\"colophon\" class=\"site-footer\" role=\"contentinfo\">\n<div class=\"footer-divider print-none\">\n<div class=\"social-links clear\">\n<div id=\"pg-26-1\" class=\"panel-grid panel-has-style\">\n<div class=\"fixlink panel-row-style panel-row-style-for-26-1\">\n<div id=\"pgc-26-1-0\" class=\"panel-grid-cell\">\n<div id=\"panel-26-1-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"1\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>General Information<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/local-health-districts\/\">VDH Local Health Department Location and Contact Information<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/06\/VDH-Monkeypox-Information-Sheet-for-HCP.pdf\">VDH Monkeypox Information Sheet for Healthcare Providers<\/a>\u00a0(PDF) (2 pp, 933 KB)\u00a0(Updated 8\/22\/22)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/06\/Monkeypox-Preparedness-Checklist-for-Healthcare-Facilities.pdf\">VDH Monkeypox Preparedness Checklist for Healthcare Facilities<\/a>\u00a0(PDF) (1 pp, 69.4 KB)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/monkeypox\">VDH 2022 Outbreak Data<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/monkeypox\/communications-resources\/\">VDH Monkeypox Communications Resources<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/index.html\">CDC Monkeypox website for Clinicians<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/clinical-recognition.html\">CDC Clinical Recognition<\/a>\u00a0(8\/5\/22)<\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/faq.html\">CDC Clinician FAQs<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/veterinarian\/index.html\">CDC Information for Veterinarians<\/a><\/li>\n<li><a href=\"https:\/\/www.hhs.gov\/about\/news\/2022\/07\/21\/fact-sheet-us-department-of-health-and-human-services-response-to-the-monkeypox-outbreak.html\">HHS Response to the Monkeypox Outbreak Fact Sheet<\/a><a id=\"mpx-testing\"><\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-26-1-0-1\" class=\"so-panel widget widget_sow-editor\" data-index=\"2\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>Testing<\/h2>\n<p>Commercial laboratory testing for monkeypox is available. VDH encourages providers to use commercial laboratories, but this testing is\u00a0<b><i>not<\/i><\/b>\u00a0free<b>.<\/b>\u00a0The laboratories will bill private insurance, Medicaid, or Medicare for all testing performed. Providers may find the relevant CPT code for Monkeypox virus testing on each commercial laboratory\u2019s website. Providers who encounter any issues while trying to order testing should contact the laboratory\u2019s client services.<\/p>\n<p>Public health testing through the Division of Consolidated Laboratory Services (DCLS) continues to be available at no cost for patients who meet\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/case-definition.html\">clinical and epidemiologic criteria<\/a>; providers should consult with their\u00a0<a href=\"https:\/\/www.vdh.virginia.gov\/local-health-districts\/\">LHD<\/a>\u00a0about this testing.<\/p>\n<h3>Labs Conducting Testing and Supporting Information<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.aegislabs.com\/news\/monkeypox\">Aegis Sciences<\/a><\/li>\n<li><a href=\"https:\/\/www.labcorp.com\/labcorp-first-national-laboratory-offer-monkeypox-test\">Labcorp<\/a><\/li>\n<li><a href=\"https:\/\/newsnetwork.mayoclinic.org\/discussion\/mayo-clinic-laboratories-launches-monkeypox-test-to-increase-access-availability\/\">Mayo Clinic Laboratories (some clinics)<\/a><\/li>\n<li><a href=\"https:\/\/www.sonichealthcareusa.com\/\">Sonic Healthcare USA<\/a><\/li>\n<li><a href=\"https:\/\/ir.questdiagnostics.com\/press-releases\/press-release-details\/2022\/Quest-Diagnostics-Launches-Monkeypox-Virus-Testing\/default.aspx\">Quest Diagnostics<\/a><\/li>\n<li><a href=\"https:\/\/dgs.virginia.gov\/globalassets\/business-units\/dcls\/documents\/hot-topic-and-updates\/monkey-pox-testing-instructions-faq-44840-2.pdf\" target=\"_blank\" rel=\"noopener\">DCLS Monkeypox Testing and Shipping Instructions<\/a>\u00a0(PDF) (4 pp, 705 KB) (8\/1\/22)<\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/prep-collection-specimens.html\">CDC Preparation and Collection of Specimens<\/a><\/li>\n<li><a href=\"https:\/\/www.fda.gov\/medical-devices\/safety-communications\/monkeypox-testing-use-lesion-swab-samples-avoid-false-results-fda-safety-communication\">FDA Safety Communication: For Monkeypox Testing, Use Lesion Swab Samples to Avoid False Results<\/a><\/li>\n<li><a href=\"https:\/\/www.ama-assn.org\/practice-management\/cpt\/orthopoxvirus-and-monkeypox-coding-guidance\">AMA Orthopoxvirus Pathology and Laboratory\/Microbiology CPT Codes<\/a>\u00a0(8\/2\/22)<\/li>\n<li>NETEC How to Collect a Monkeypox Specimen for Diagnostic Testing\u00a0(8\/11\/22)\n<ul>\n<li><a href=\"https:\/\/netec.org\/2022\/07\/26\/how-to-collect-a-monkeypox-specimen-for-diagnostic-testing\/\">Video<\/a><a id=\"mpx-ipc\"><\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-26-1-0-2\" class=\"so-panel widget widget_sow-editor\" data-index=\"3\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>Infection Prevention &amp; Control<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/05\/VDH-Managing-Exposed-HCP.docx\">VDH Assessing and Managing Exposed Healthcare Personnel<\/a>\u00a0(DOCX) (7 pp, 58 KB) (8\/12\/22)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/06\/Monkeypox-Infection-Prevention-and-Control-Recommendations-for-Healthcare-Settings.pdf\">VDH Monkeypox Infection Prevention and Control Recommendations for Healthcare Settings<\/a>\u00a0(PDF) (4 pp, 283 KB)<\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/infection-control-home.html\">CDC Isolation and Infection Control<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/Monkeypox-Interim-Guidance-for-Household-Disinfection-508.pdf\">CDC Interim Guidance for Household Disinfection of Monkeypox Virus<\/a>\u00a0(PDF) (5 pp, 181 KB)<\/li>\n<\/ul>\n<h3>Emergency Transport<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/emergency-medical-services\/emergency-operations\/emerging-infectious-diseases-information\/information-on-monkey-pox-for-ems\/\">VDH Office of Emergency Medical Services monkeypox website<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-26-1-0-3\" class=\"so-panel widget widget_sow-editor\" data-index=\"4\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2><a id=\"mpx-info-patients\"><\/a>Information for Patients and Close Contacts<\/h2>\n<ul>\n<li>VDH Monkeypox Handouts for Patients and Close Contacts\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/VDH-Monkeypox-factsheet-for-Patient.pdf\">Patients<\/a>\u00a0(PDF) (1 pp, 100 KB),\u00a0<a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/VDH_monkeypox-factsheet._for-patient_ES.pdf\">Spanish<\/a>\u00a0(PDF) (1pp, 96 KB)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/VDH-Monkeypox-factsheet-for-Low-Risk-CC.pdf\">Close Contact (Low Risk)<\/a>\u00a0(PDF) (1 pp, 321 KB),\u00a0<a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/VDH_monkeypox-factsheet._low-risk_ES.pdf\">Spanish<\/a>\u00a0(PDF) (1pp, 312KB)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/VDH-Monkeypox-factsheet-for-Intermed-Risk-CC.pdf\">Close Contact (Intermediate Risk)<\/a>\u00a0(PDF) (1 pp, 309 KB),\u00a0<a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/VDH_monkeypox-factsheet_intermediate-risk_ES.pdf\">Spanish<\/a>\u00a0(PDF) (1pp, 312KB)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/VDH-Monkeypox-factsheet-for-High-Risk-CC.pdf\">Close Contact (High Risk)<\/a>\u00a0(PDF) (1 pp, 309 KB),\u00a0<a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/VDH_monkeypox-factsheet_high-risk_ES.pdf\">Spanish<\/a>\u00a0(PDF) (1pp, 312KB)<a id=\"mpx-treatment\"><\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-26-1-0-4\" class=\"so-panel widget widget_sow-editor\" data-index=\"5\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>Treatment<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/monkeypox\/healthcare-providers\/treatment-guidance\/\">VDH Healthcare Provider Treatment Information\u00a0<\/a><b><a id=\"mpx-vaccine\"><\/a><\/b><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-26-1-0-5\" class=\"so-panel widget widget_sow-editor\" data-index=\"6\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2><b>Vaccine Information<\/b><\/h2>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/monkeypox\/healthcare-providers\/vaccines-guidance\/\">VDH Healthcare Provider Information for Vaccine<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/interim-considerations\/jynneos-vaccine.html\">CDC Jynneos Vaccine<\/a>\u00a0(8\/11\/22)<\/li>\n<li><a href=\"https:\/\/www.youtube.com\/watch?v=TLv1mR6mECQ\">CDC Video on Administering JYNNEOS Intradermally<\/a>\u00a0(8\/11\/22)<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-26-1-0-6\" class=\"so-panel widget widget_sow-editor\" data-index=\"7\">\n<div class=\"mpx-special-pop panel-widget-style panel-widget-style-for-26-1-0-6\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>Special Populations or Settings<\/h2>\n<h3>Clinical Guidance<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/people-with-HIV.html\">CDC Clinical Considerations for Treatment and Prophylaxis of Monkeypox Virus Infection in People with HIV<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/pregnancy.html\">CDC Clinical Considerations for Monkeypox in People Who are Pregnant or Breastfeeding<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/pediatric.html\">CDC Clinical Considerations for Monkeypox in Children and Adolescents<\/a>\u00a0(7\/27\/22)<\/li>\n<\/ul>\n<h3>Congregate Settings<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/Guidance-IHE-Monkeypox.pdf\">VDH What Institutions of Higher Education Need to Know about Monkeypox<\/a>\u00a0(PDF) (2pp, 121 KB)\u00a0(7\/26\/22)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/08\/VDH-Information-for-K12-and-Child-Care.pdf\">VDH What K-12 Schools and Child Care Facilities Need to Know about Monkeypox<\/a>\u00a0(PDF) (2pp, 388KB)\u00a0(New- 8\/18\/22)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/Guidance-Correctional-Facilities-Monkeypox.pdf\">VDH What Correctional and Detention Facilities Need to Know about Monkeypox<\/a>\u00a0(PDF) (2pp, 121 KB)\u00a0(7\/26\/22)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/Guidance-Homeless-Shelters-Monkeypox.pdf\">VDH What Homeless Shelters Need to Know about Monkeypox<\/a>\u00a0(PDF) (2pp, 120KB)\u00a0(7\/26\/22)<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-26-1-0-7\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"8\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2><a id=\"mpx-hcp-outreach\"><\/a>Clinician Outreach<\/h2>\n<h3>Webinars<\/h3>\n<ul>\n<li><a href=\"https:\/\/emergency.cdc.gov\/coca\/calls\/2022\/callinfo_081122.asp\">CDC COCA Call: CDC and FDA Update: Interim Clinical Considerations for Monkeypox Vaccination (8\/11\/22)<\/a>\n<ul>\n<li><a href=\"https:\/\/emergency.cdc.gov\/coca\/ppt\/2022\/081122_slides.pdf\">Presentation Slide Set<\/a><\/li>\n<\/ul>\n<\/li>\n<li>VDH: What Healthcare Professionals Need to Know About Monkeypox (8\/9\/22)\n<ul>\n<li><a href=\"https:\/\/vhass.org\/wp-content\/uploads\/2022\/08\/What-Clinicians-Need-to-Know-About-Monkeypox-_VHHA.pdf\">Presentation Slide Set<\/a><\/li>\n<li><a href=\"https:\/\/attendee.gotowebinar.com\/recording\/5981902232006139649\">Recording<\/a>(<a href=\"https:\/\/youtu.be\/Wg1ILdr3X6c\">Youtube link<\/a>)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/08\/VDH-FAQs-for-LHDs.pdf\">VDH FAQs about Monkeypox for Local Health Districts and Healthcare Providers<\/a>\u00a0(New - 8\/16\/22)<\/li>\n<\/ul>\n<\/li>\n<li><a href=\"https:\/\/emergency.cdc.gov\/coca\/calls\/2022\/callinfo_072622.asp\">CDC COCA Call: Monkeypox Outbreak: Updates on the Epidemiology, Testing, Treatment, and Vaccination (7\/26\/22)<\/a><\/li>\n<li><a href=\"https:\/\/www.idsociety.org\/multimedia\/clinician-calls\/cdcidsa-monkeypox-updates-on-testing-vaccination--treatment\/\">CDC\/IDSA Clinician Call: Monkeypox: Updates on Testing, Vaccination &amp; Treatment<\/a>\u00a0(7\/26\/22)<\/li>\n<li><a href=\"https:\/\/vcu.cloud-cme.com\/course\/courseoverview?P=0&amp;EID=27502\">Virginia Infection Prevention\u00a0Training\u00a0Center: Monkeypox Update (7\/8\/22)\u00a0<\/a>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/07\/Monkeypox-VIPTC-VDH-Presentation-7-8-22.pdf\">Presentation Slide set<\/a>\u00a0(PDF) (33pp, 1495 KB)<\/li>\n<li><a href=\"https:\/\/vcu.cloud-cme.com\/course\/courseoverview?P=0&amp;EID=27502\">View this webinar<\/a>\u00a0and receive CE credit<\/li>\n<\/ul>\n<\/li>\n<li><a href=\"https:\/\/emergency.cdc.gov\/coca\/calls\/2022\/callinfo_062922.asp\">CDC COCA Call: Monkeypox: Updates about Clinical Diagnosis and Treatment<\/a>\u00a0(6\/29\/22)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/06\/CDC-Update-on-the-Use-of-Medical-Countermeasures-for-Monkeypox-Infection-slides.pdf\">CDC Update on the Use of Medical Countermeasures for Monkeypox Infection slides<\/a>\u00a0(PDF) (39 pp, 1356 KB)(6\/23\/22)<\/li>\n<li>VDH Monkeypox Outbreak Briefing for MSV and Virginia Healthcare Providers (6\/10\/22)\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/214\/2022\/06\/VDH-MPX-Outbreak-Briefing-for-MSV-61022.pdf\">Slides Set<\/a>\u00a0(PDF) (36 pp, 1170 KB)<\/li>\n<li><a href=\"https:\/\/www.youtube.com\/watch?v=2SQFwj-7gLc&amp;list=PLzUgsvmTbfxRwpXc1mDnzznffQTiFIJ9c&amp;index=16\">Recording<\/a><\/li>\n<\/ul>\n<\/li>\n<li><a href=\"https:\/\/emergency.cdc.gov\/coca\/calls\/2022\/callinfo_052422.asp\">CDC COCA Call: What Healthcare Providers Need to Know about Monkeypox in the United States and Other Countries (5\/24\/22)<\/a>\n<ul>\n<li><a href=\"https:\/\/vdhweb.vdh.virginia.gov\/surveillance-and-investigation\/wp-content\/uploads\/sites\/26\/2022\/06\/COCA-Call-Monkeypox-Slides.pdf\">Slides<\/a>\u00a0(PDF) (59 pp, 2.8 MB)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3>Clinician Letters and CDC Health Advisories<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/clinicians\/clinician-letters\/\">VDH Clinician Letters<\/a><\/li>\n<li><a href=\"https:\/\/emergency.cdc.gov\/han\/2022\/han00472.asp\">CDC Health Alert Network (HAN) Health Advisory: Update for Clinicians on Monkeypox in People with HIV, Children and Adolescents, and People who are Pregnant or Breastfeeding - 8\/1\/22\u00a0<\/a><\/li>\n<li><a href=\"https:\/\/emergency.cdc.gov\/han\/2022\/han00471.asp\">CDC Health Alert Network (HAN) Health Advisory: Update for Clinicians on Testing and Treatment for Monkeypox - 7\/28\/22<\/a><\/li>\n<li><a href=\"https:\/\/emergency.cdc.gov\/han\/2022\/han00468.asp\">CDC Health Alert Network (HAN) Health Advisory: Updated Case-finding Guidance: Monkeypox Outbreak\u2014United States - 6\/14\/22<\/a><\/li>\n<li><a href=\"https:\/\/emergency.cdc.gov\/han\/2022\/han00466.asp\">CDC Health Alert Network (HAN) Health Advisory: Monkeypox Virus Infection in the United States and Other Non-endemic Countries\u20142022 - 5\/20\/22<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-26-2\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-26-2\">\n<div id=\"pgc-26-2-0\" class=\"panel-grid-cell\">\n<div id=\"panel-26-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"9\">\n<div class=\"panel-widget-style panel-widget-style-for-26-2-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<p>&nbsp;<\/p>\n<hr \/>\n<div id=\"pg-28-2\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-28-2\">\n<div id=\"pgc-28-2-0\" class=\"panel-grid-cell\">\n<div id=\"panel-28-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"2\">\n<div id=\"role-hcp\" class=\"panel-widget-style panel-widget-style-for-28-2-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>Role of a Healthcare Provider in the Monkeypox Vaccination Response<\/h2>\n<p>Healthcare providers should be aware of the groups of people recommended for monkeypox vaccination and the currently available vaccines. Providers should refer those eligible for vaccination to their Local Health District for more information on how to receive a vaccination.\u00a0<b>Monkeypox vaccine is not routinely recommended for the general public, and is intended to be used in very specific groups that have a higher risk for exposure.\u00a0<\/b><\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/what-hcps-should-know.html\">CDC What Healthcare Professionals Should Know<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-28-3\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-28-3\">\n<div id=\"pgc-28-3-0\" class=\"panel-grid-cell\">\n<div id=\"panel-28-3-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"3\">\n<div id=\"available-vaccines\" class=\"panel-widget-style panel-widget-style-for-28-3-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2><b>Currently Available Vaccines\u00a0<\/b><\/h2>\n<p>Two vaccines may be used for the prevention of\u00a0<i>Monkeypox virus<\/i>\u00a0infection:<\/p>\n<ul>\n<li>JYNNEOS (also known as Imvamune or Imvanex), licensed (or approved) by the U.S. Food and Drug Administration (FDA) for the prevention of\u00a0<i>Monkeypox virus<\/i>\u00a0infection in adults and authorized for use for individuals under the age of 18 years old.<\/li>\n<li>ACAM2000, licensed (or approved) by FDA for use against\u00a0<i>Smallpox virus<\/i>\u00a0and made available for use against\u00a0<i>Monkeypox virus<\/i>\u00a0under an\u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/investigational-new-drug-ind-application\/ind-applications-clinical-treatment-expanded-access-overview\">Expanded Access Investigational New Drug (IND)<\/a>\u00a0application.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-28-3-0-1\" class=\"so-panel widget widget_sow-editor\" data-index=\"4\">\n<div id=\"JYNNEOS\" class=\"panel-widget-style panel-widget-style-for-28-3-0-1\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h3>JYNNEOS<\/h3>\n<p>JYNNEOS is an attenuated live virus vaccine which has been approved or authorized for the prevention of monkeypox.<\/p>\n<ul>\n<li>For more information about JYNNEOS, please refer to the\u00a0<a href=\"https:\/\/www.fda.gov\/media\/131078\/download\">Package Insert<\/a>, as well as\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/considerations-for-monkeypox-vaccination.html#JYNNEOS-special-considerations\">CDC JYNNEOS Special Considerations<\/a>.<\/li>\n<li>For more information and guidance on the Emergency Use Authorization (EUA) for JYNNEOS use for individuals under the age of 18 years old, please refer to the\u00a0<a href=\"https:\/\/www.fda.gov\/media\/160774\/download\">EUA HCP Fact Sheet<\/a>\u00a0and the\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/considerations-for-monkeypox-vaccination.html\">CDC Interim Clinical Considerations for Monkeypox<\/a>.<\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/smallpox-monkeypox.html\">Smallpox\/Monkeypox Vaccine (JYNNEOS) Vaccine Information Statement<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-28-3-0-2\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"5\">\n<div id=\"ACAM2000\" class=\"panel-widget-style panel-widget-style-for-28-3-0-2\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h3>ACAM2000<\/h3>\n<p>ACAM2000 contains a live replicating vaccinia virus, licensed by the FDA for immunization in people who are at high risk for smallpox infection. ACAM2000 may be used as an alternative to JYNNEOS vaccine.<\/p>\n<ul>\n<li>For more information about ACAM2000, please refer to the\u00a0<a href=\"http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM142572.pdf\">ACAM2000 Package Insert<\/a>, as well as\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/considerations-for-monkeypox-vaccination.html#ACAM2000-special-considerations\">CDC ACAM2000 Special Considerations<\/a><\/li>\n<li><a href=\"http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM142576.pdf\">FDA Medication Guide for ACAM2000\u00a0<\/a><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-28-4\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-28-4\">\n<div id=\"pgc-28-4-0\" class=\"panel-grid-cell\">\n<div id=\"panel-28-4-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"6\">\n<div id=\"vaccination-strategies\" class=\"panel-widget-style panel-widget-style-for-28-4-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2><b>Vaccination Strategies to Prevent Monkeypox<\/b><\/h2>\n<p>When properly administered before or after a recent exposure, vaccines can be effective tools at protecting people against monkeypox illness. Either JYNNEOS or ACAM2000 can be used for Post-Exposure Prophylaxis (PEP), Expanded PEP (i.e., PEP++), or Pre-Exposure Prophylaxis (PrEP), following risk-benefit discussions and a review of conditions that could increase risk for serious adverse events. At this time, JYNNEOS is the primary vaccine used in Virginia for prevention of monkeypox.<\/p>\n<p>Please see the\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/considerations-for-monkeypox-vaccination.html#vaccine-strategies\">CDC Considerations for Monkeypox Vaccination Guidance<\/a>\u00a0for detailed information about these strategies.<\/p>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/monkeypox\/healthcare-providers\/vaccine-guidance\/#pep\">PEP<\/a>:\u00a0Vaccination after a known monkeypox exposure for those who meet certain\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/monitoring.html\">risk criteria<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/monkeypox\/healthcare-providers\/vaccine-guidance\/#expanded-pep\">PEP++:<\/a>\u00a0Vaccination of people with\u00a0<a href=\"https:\/\/docs.google.com\/document\/d\/1ZxQp1RsDKZkWCZzBouCLi0eMdiHLJ4hO2fUgoZdqZtA\/edit#bookmark=id.hchrkquzauwa\">certain risk factors<\/a>\u00a0who are more likely to have been recently exposed to monkeypox, but do not have a documented known exposure<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/monkeypox\/healthcare-providers\/vaccine-guidance\/#prep\">PrEP<\/a>:\u00a0Vaccination of those at high risk for coming in contact with monkeypox virus, such as laboratory workers performing monkeypox diagnostic testing<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-28-4-0-1\" class=\"so-panel widget widget_sow-editor\" data-index=\"7\">\n<div id=\"pep\" class=\"panel-widget-style panel-widget-style-for-28-4-0-1\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h3>Post-Exposure Prophylaxis (PEP)<\/h3>\n<p>Following exposure of a confirmed monkeypox case, the CDC recommends that the vaccine be given as soon as possible after exposure, preferably\u00a0within 4 days.<\/p>\n<p><b>Consider vaccine for PEP in the following situations:<\/b><\/p>\n<ul>\n<li>During days 0-4 after exposure for\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/monitoring.html\">intermediate- and high-risk contacts<\/a>\u00a0to prevent onset of disease.\u00a0<b>The sooner an exposed person gets the vaccine, the better.<\/b><\/li>\n<li>During days 4-14 after the exposure for high-risk contacts. Vaccination may reduce the symptoms of disease, but may not prevent the disease.<\/li>\n<li>During days 4-14 after the exposure for intermediate-risk contacts, informed decision making is recommended on an individual basis to determine whether benefits of PEP outweigh the risks.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-28-4-0-2\" class=\"so-panel widget widget_sow-editor\" data-index=\"8\">\n<div id=\"expanded-pep\" class=\"panel-widget-style panel-widget-style-for-28-4-0-2\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h3>Expanded PEP (PEP++)<\/h3>\n<p>Healthcare providers should work with their local health district to refer eligible patients for vaccination. Vaccine supply is currently limited, however, as additional vaccine supply becomes available, vaccines may become available directly to certain providers who work closely with high risk populations. Until that time, providers should work with their local health department to get their high-risk patients vaccinated.<\/p>\n<h4>Groups Recommended for Monkeypox Expanded PEP in Virginia:<\/h4>\n<p><b>Eligible recipients include:\u00a0<\/b><\/p>\n<ul>\n<li>All people, of any sexual orientation or gender, who have had anonymous or multiple (more than 1) sexual partners in the last 2 weeks; or<\/li>\n<li>Sex workers (of any sexual orientation or gender); or<\/li>\n<li>Staff (of any sexual orientation or gender) at establishments where sexual activity occurs (bathhouses, saunas, sex clubs).<\/li>\n<\/ul>\n<p>When coupled with self-isolation and other prevention measures when symptoms first occur, Expanded PEP may help slow the spread of the disease in areas with large numbers of monkeypox cases.<\/p>\n<p><b>Note:\u00a0<\/b>Persons living with HIV or other immune-compromising conditions may be at higher risk for severe outcomes and should be a high priority for vaccination, specifically JYNNEOS,<i>\u00a0if they fall into any of the groups recommended for monkeypox Expanded PEP (as listed above).\u00a0<\/i>For persons living with HIV, please refer to\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/people-with-HIV.html\">CDC Clinical Considerations for Treatment and Prophylaxis of Monkeypox Virus Infection in People with HIV<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-28-4-0-3\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"9\">\n<div id=\"prep\" class=\"panel-widget-style panel-widget-style-for-28-4-0-3\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h3>Pre-Exposure Prophylaxis (PrEP)<\/h3>\n<p><b>At this time, most clinicians and laboratorians in the United States are not advised to receive monkeypox vaccine PrEP.<\/b>.\u00a0For additional information regarding PrEP, visit\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/smallpox-vaccine.html#pre-exposure\">CDC Monkeypox and Smallpox Vaccine Guidance.<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-28-5\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-28-5\">\n<div id=\"pgc-28-5-0\" class=\"panel-grid-cell\">\n<div id=\"panel-28-5-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"10\">\n<div id=\"requirements\" class=\"panel-widget-style panel-widget-style-for-28-5-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2><strong>Vaccination Requirements<\/strong><\/h2>\n<p><b>The VDH requires proof of Virginia residency to receive monkeypox vaccination.<\/b>\u00a0Exceptions may be made on a case-by-case basis.<\/p>\n<p><b>For Health Care Providers Administering Monkeypox Vaccines:\u00a0<\/b><\/p>\n<ul>\n<li>All\u00a0vaccine providers in Virginia must report any doses administered to the\u00a0<a href=\"https:\/\/viis.vdh.virginia.gov\/VIIS\/portalInfoManager.do\">Virginia Immunization Information System (VIIS)<\/a>.<\/li>\n<li>Vaccine adverse events for monkeypox vaccines will be monitored through Vaccine Adverse Events Reporting System (VAERS) along with CDC vaccine surveillance systems: the Vaccine Safety Datalink (VSD) and the Clinical Immunization Safety Assessment (CISA) team. For more information, visit\u00a0<a href=\"https:\/\/www.cdc.gov\/vaccinesafety\/ensuringsafety\/monitoring\/index.html\">Vaccine Safety Monitoring | Vaccine Safety | CDC<\/a><b>.<\/b><\/li>\n<li><b><\/b><b>Providers should report any clinically significant adverse event following vaccination to the\u00a0<\/b><strong><a href=\"https:\/\/vaers.hhs.gov\/\">VAERS<\/a><\/strong><b>.<\/b>\n<ul>\n<li>For VAERS questions, email\u00a0info@VAERS.org, or call 1-800-822-7967 from Monday through Friday between 9 a.m. to 5 p.m. ET.<\/li>\n<li>For more information visit\u00a0<a href=\"https:\/\/www.cdc.gov\/vaccinesafety\/ensuringsafety\/monitoring\/vaers\/index.html\">CDC VAERS<\/a>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-28-6\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-28-6\">\n<div id=\"pgc-28-6-0\" class=\"panel-grid-cell\">\n<div id=\"panel-28-6-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"11\">\n<div id=\"more-information\" class=\"panel-widget-style panel-widget-style-for-28-6-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>Additional Information<\/h2>\n<ul>\n<li>CDC\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/standing-orders-for-administering-vaccine.pdf\">JYNNEOS Standing Order Template (for 18 years and older)<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/Storage-and-Handling-Summary.pdf\">CDC JYNNEOS Storage and Handling Summary<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/smallpox-monkeypox.html\">Smallpox\/Monkeypox Vaccine (JYNNEOS) Vaccine Information Statement<\/a><\/li>\n<li><a href=\"https:\/\/www.fda.gov\/media\/131078\/download\">Package Insert - JYNNEOS<\/a><\/li>\n<li><a href=\"https:\/\/www.youtube.com\/watch?v=TLv1mR6mECQ\">CDC Video on Administering JYNNEOS Intradermally<\/a>\u00a0(8\/11\/22)<\/li>\n<li><a href=\"http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM142576.pdf\">Medical Guide for vaccination with ACAM2000\u00a0<\/a><\/li>\n<li><a href=\"http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM142572.pdf\">ACAM2000 Package Insert<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/smallpox-vaccine.html\">Monkeypox and Smallpox Vaccine Guidance<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7122e1.htm\">Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/smallpox-vaccine.html\">CDC Monkeypox and Smallpox Vaccine Guidance<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/emergency-preparedness\/emergency-preparedness\/monkeypox-administering-acam2000-smallpox-vaccine-train-the-trainer-training\/\">VDH Information and Schedule for Administering ACAM2000 Smallpox Vaccine Train-the-Trainer Trainings<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/smallpox-monkeypox.html\">CDC Smallpox\/Monkeypox Vaccine Information Statements<\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7122e1.htm\">MMWR: Use of JYNNEOS for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: ACIP Recommendations<\/a><\/li>\n<li><a href=\"https:\/\/www.ama-assn.org\/practice-management\/cpt\/orthopoxvirus-and-monkeypox-coding-guidance\">AMA Smallpox &amp; Monkeypox Immunization CPT Codes<\/a>\u00a0(8\/2\/22)<\/li>\n<\/ul>\n<\/div>\n<hr \/>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-30-1\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-30-1\">\n<div id=\"pgc-30-1-0\" class=\"panel-grid-cell\">\n<div id=\"panel-30-1-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"1\">\n<div id=\"symptoms\" class=\"talking-points-list panel-widget-style panel-widget-style-for-30-1-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<p>Currently there is no treatment approved specifically for monkeypox virus infections. However, antivirals developed for use in patients with smallpox may prove beneficial against monkeypox. CDC provides Interim Clinical Guidance for the Treatment of Monkeypox.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-30-2\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-30-2\">\n<div id=\"pgc-30-2-0\" class=\"panel-grid-cell\">\n<div id=\"panel-30-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"2\">\n<div class=\"panel-widget-style panel-widget-style-for-30-2-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>Guidance on Tecovirimat (TPOXX) for Monkeypox<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-30-2-0-1\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"3\">\n<div class=\"talking-points-list panel-widget-style panel-widget-style-for-30-2-0-1\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<p>Many people infected with monkeypox virus have a\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/clinical-recognition.html\">mild, self-limiting disease course<\/a>\u00a0in the absence of specific therapy. However, the prognosis for monkeypox depends on multiple factors, such as previous vaccination status, initial health status, concurrent illnesses, and comorbidities among others. More information can be found on the\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html\">CDC\u2019s Interim Clinical Guidance for the Treatment of Monkeypox<\/a>.<\/p>\n<p>For information regarding who is eligible for tecovirimat (TPOXX) treatment, see the\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/Tecovirimat.html\">CDC Guidance for Tecovirimat<\/a>.<\/p>\n<p>For information about Monkeypox Treatment in patients with HIV, see the\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/people-with-HIV.html\">CDC Clinical Considerations for Treatment and Prophylaxis of Monkeypox Virus Infection in People with HIV<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-30-3\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-30-3\">\n<div id=\"pgc-30-3-0\" class=\"panel-grid-cell\">\n<div id=\"panel-30-3-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"4\">\n<div class=\"panel-widget-style panel-widget-style-for-30-3-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>As a healthcare provider, how do I request TPOXX treatment?<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-30-3-0-1\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"5\">\n<div class=\"talking-points-list panel-widget-style panel-widget-style-for-30-3-0-1\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<p>TPOXX is available through the CDC\u2019s Strategic National Stockpile (SNS).\u00a0<b>To request TPOXX, clinicians may complete the\u00a0<\/b><a href=\"https:\/\/redcap.vdh.virginia.gov\/redcap\/surveys\/?s=MERAYDMFMA\"><b>TPOXX Treatment Initiation Interest Form<\/b><\/a>. The VDH has a small stock available for deployment upon request and has the ability to order more at any time through the SNS. The VDH also has the ability to request direct shipment from the SNS to the clinician, if needed.<\/p>\n<p><b>Prescribers must complete the\u00a0<\/b><a href=\"https:\/\/redcap.vdh.virginia.gov\/redcap\/surveys\/?s=743LJ8KCJH\"><b>TPOXX Patient Initiation Survey<\/b><\/a><b>\u00a0for all patients who are started on TPOXX.<\/b><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-30-4\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-30-4\">\n<div id=\"pgc-30-4-0\" class=\"panel-grid-cell\">\n<div id=\"panel-30-4-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"6\">\n<div class=\"panel-widget-style panel-widget-style-for-30-4-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>What are the requirements for TPOXX prescribing\/initiating?<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-30-4-0-1\" class=\"so-panel widget widget_sow-editor\" data-index=\"7\">\n<div class=\"talking-points-list panel-widget-style panel-widget-style-for-30-4-0-1\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<p>The CDC holds an\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=312.315\">intermediate-size patient population EA-IND\u00a0<\/a>(IND 116,039\/Protocol 6402) to allow access to and use of TPOXX for orthopoxvirus infections, including monkeypox. The EA-IND provides an umbrella regulatory coverage so that clinicians and facilities do not need to request and obtain their own INDs. The EA-IND also provides liability coverage under the\u00a0<a href=\"https:\/\/www.phe.gov\/Preparedness\/legal\/prepact\/Pages\/prepqa.aspx\">PREP Act\u00a0<\/a>for compensation to patients if injured via the Countermeasure Injury Compensation Program (<a href=\"https:\/\/www.hrsa.gov\/cicp\">CICP<\/a>).<\/p>\n<p>Clinicians interested in prescribing TPOXX for the treatment of monkeypox should review the\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/obtaining-tecovirimat.html\">CDC requirements.<\/a>\u00a0Clinicians wishing to initiate treatment for Monkeypox should be prepared to complete the following documentation:<\/p>\n<ol>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/Tecovirimat-IND-Form-FDA-1572.pdf\"><b>FDA Form 1572<\/b><\/a>. One signed 1572 per facility suffices for all tecovirimat treatments administered under the EA-IND at the same facility.<\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/Attachment-1-Informed-Consent.pdf\"><b>Informed consent<\/b><\/a>. Obtain prior to treatment.<\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/Attachment-2-Form-A-Patient-Intake-Form.pdf\"><b>Patient intake form<\/b><\/a><\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/Attachment-2-Form-B-Clinical-Outcome-Form.pdf\"><b>Clinical Outcome Form<\/b><\/a>. Provides clinical progress of patients during TPOXX therapy (e.g., at Day 7). If the patient\u2019s clinical condition necessitates performing clinical labs, please include a copy of the results.<\/li>\n<li><a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/MedWatchForm-for-Tpoxx.pdf\"><b>Adverse event form<\/b><\/a>. Life-threatening or serious adverse events associated with TPOXX use should be reported to CDC (regaffairs@cdc.gov) within 24 hours of occurrence, or as soon as possible.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-30-4-0-2\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"8\">\n<div class=\"talking-points-list panel-widget-style panel-widget-style-for-30-4-0-2\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h3>Optional documentation:<\/h3>\n<h4><b>Photos of lesions.<\/b><\/h4>\n<p>Ideally, a photograph of at least 1 lesion prior to tecovirimat treatment and then the same lesion photographed again during treatment between days 7 and 14 (indicated dates on photos). Provide photo(s) of any new lesions that develop during or up to 7 days after completion of TPOXX treatment.<\/p>\n<h4><b>Samples of lesions for molecular testing.<\/b><\/h4>\n<p>Ideally, a sample from at least 1 lesion prior to tecovirimat treatment but only if baseline diagnostic testing wasn\u2019t performed, as well as samples from any new lesions that develop during TPOXX treatment or up to 7 days afterwards to assess for development antiviral resistance mutations. Submit samples to CDC with\u00a0<a href=\"https:\/\/www.cdc.gov\/laboratory\/specimen-submission\">CDC Form 50.34<\/a>, and indicate\u00a0<a href=\"https:\/\/www.cdc.gov\/laboratory\/specimen-submission\/detail.html?CDCTestCode=CDC-10515\">Poxvirus Molecular Detection (CDC-10515)<\/a>\u00a0as the test order (code).<\/p>\n<p>Providers who agree to complete the above documentation and submit documentation to the CDC may obtain TPOXX by completing the\u00a0<a href=\"https:\/\/redcap.vdh.virginia.gov\/redcap\/surveys\/?s=MERAYDMFMA\">TPOXX Treatment Initiation Interest Form<\/a>.\u00a0<b>Prescribers must complete the\u00a0<\/b><a href=\"https:\/\/redcap.vdh.virginia.gov\/redcap\/surveys\/?s=743LJ8KCJH\"><b>TPOXX Patient Initiation Survey<\/b><\/a><b>\u00a0for all patients who are started on TPOXX.<\/b><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-30-5\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-30-5\">\n<div id=\"pgc-30-5-0\" class=\"panel-grid-cell\">\n<div id=\"panel-30-5-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"9\">\n<div class=\"panel-widget-style panel-widget-style-for-30-5-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>What precautions are associated with TPOXX?<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-30-5-0-1\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"10\">\n<div class=\"talking-points-list panel-widget-style panel-widget-style-for-30-5-0-1\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<p>Adverse reactions and drug interactions, as well as special population considerations (pregnancy\/lactation and pediatrics) can be found on\u00a0the\u00a0<a href=\"https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html\">CDC\u2019s Interim Clinical Guidance for the Treatment of Monkeypox<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"pg-30-6\" class=\"panel-grid panel-has-style\">\n<div class=\"panel-row-style panel-row-style-for-30-6\">\n<div id=\"pgc-30-6-0\" class=\"panel-grid-cell\">\n<div id=\"panel-30-6-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"11\">\n<div class=\"panel-widget-style panel-widget-style-for-30-6-0-0\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<h2>Can I charge my patient for TPOXX?<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"panel-30-6-0-1\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"12\">\n<div class=\"talking-points-list panel-widget-style panel-widget-style-for-30-6-0-1\">\n<div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n<p>No, the drug should be provided at no cost. There is no funding available to assist with laboratory testing. Testing plasma PK samples collected and sent by the hospital to the lab contracted to test PK samples and\/or blood or specimens sent via the health department to CDC for serology or virologic testing would not have a cost to the patient.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>Last updated: August 22, 2022<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/footer>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>If you are evaluating a patient suspected to have monkeypox, immediately report the suspected case to the local health department (LHD)\u00a0using the\u00a0Confidential Morbidity Report Portal\u00a0(Epi-1) or telephone, even if testing is being conducted at a commercial laboratory. General Information VDH Local Health Department Location and Contact Information VDH Monkeypox Information Sheet for Healthcare Providers\u00a0(PDF) (2 [&hellip;]<\/p>\n","protected":false},"author":339,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"tags":[],"class_list":["post-578","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Monkeypox Information for Healthcare Professionals - Hampton &amp; Peninsula Health Districts<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monkeypox Information for Healthcare Professionals - Hampton &amp; Peninsula Health Districts\" \/>\n<meta property=\"og:description\" content=\"If you are evaluating a patient suspected to have monkeypox, immediately report the suspected case to the local health department (LHD)\u00a0using the\u00a0Confidential Morbidity Report Portal\u00a0(Epi-1) or telephone, even if testing is being conducted at a commercial laboratory. General Information VDH Local Health Department Location and Contact Information VDH Monkeypox Information Sheet for Healthcare Providers\u00a0(PDF) (2 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/\" \/>\n<meta property=\"og:site_name\" content=\"Hampton &amp; Peninsula Health Districts\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-22T20:25:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/monkeypox-information-for-healthcare-professionals\\\/\",\"url\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/monkeypox-information-for-healthcare-professionals\\\/\",\"name\":\"Monkeypox Information for Healthcare Professionals - Hampton &amp; Peninsula Health Districts\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/#website\"},\"datePublished\":\"2022-08-02T12:36:14+00:00\",\"dateModified\":\"2022-08-22T20:25:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/monkeypox-information-for-healthcare-professionals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/monkeypox-information-for-healthcare-professionals\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/monkeypox-information-for-healthcare-professionals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Monkeypox Information for Healthcare Professionals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/#website\",\"url\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/\",\"name\":\"Hampton &amp; Peninsula Health Districts\",\"description\":\"Your friendly local health department!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/hampton-peninsula\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Monkeypox Information for Healthcare Professionals - Hampton &amp; Peninsula Health Districts","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/","og_locale":"en_US","og_type":"article","og_title":"Monkeypox Information for Healthcare Professionals - Hampton &amp; Peninsula Health Districts","og_description":"If you are evaluating a patient suspected to have monkeypox, immediately report the suspected case to the local health department (LHD)\u00a0using the\u00a0Confidential Morbidity Report Portal\u00a0(Epi-1) or telephone, even if testing is being conducted at a commercial laboratory. General Information VDH Local Health Department Location and Contact Information VDH Monkeypox Information Sheet for Healthcare Providers\u00a0(PDF) (2 [&hellip;]","og_url":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/","og_site_name":"Hampton &amp; Peninsula Health Districts","article_modified_time":"2022-08-22T20:25:01+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/","url":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/","name":"Monkeypox Information for Healthcare Professionals - Hampton &amp; Peninsula Health Districts","isPartOf":{"@id":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/#website"},"datePublished":"2022-08-02T12:36:14+00:00","dateModified":"2022-08-22T20:25:01+00:00","breadcrumb":{"@id":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/monkeypox-information-for-healthcare-professionals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/"},{"@type":"ListItem","position":2,"name":"Monkeypox Information for Healthcare Professionals"}]},{"@type":"WebSite","@id":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/#website","url":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/","name":"Hampton &amp; Peninsula Health Districts","description":"Your friendly local health department!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/pages\/578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/users\/339"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/comments?post=578"}],"version-history":[{"count":5,"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/pages\/578\/revisions"}],"predecessor-version":[{"id":621,"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/pages\/578\/revisions\/621"}],"wp:attachment":[{"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/media?parent=578"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vdh.virginia.gov\/hampton-peninsula\/wp-json\/wp\/v2\/tags?post=578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}